BNGO - Company ID 0001411690
The table below shows Bionano Genomics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.99M | $9.17M | $17.95M | $5.09M | $24.57M | $38.45M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $5.20M | $4.75M | $9.32M | $7.02M | $4.93M | $2.78M |
| Inventory | $7.83M | $13.28M | $27.60M | $29.76M | $12.39M | $3.32M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $45.39M |
| $39.49M |
| $140.12M |
| $157.30M |
| $272.41M |
| $46.79M |
| Property, plant & equipment | $14.85M | $19.22M | $23.34M | $18.03M | $10.32M | $4.91M |
| Goodwill | - | $0.00 | $0.00 | $77.29M | $56.16M | $7.17M |
| Total assets | $73.58M | $76.67M | $214.40M | $307.50M | $377.10M | $60.45M |
| Accounts payable | $5.59M | $6.96M | $10.38M | $12.53M | $9.70M | $2.93M |
| Total current liabilities | $22.94M | $37.34M | $100.03M | $35.88M | $21.84M | $8.94M |
| Long-term debt | - | - | - | - | $0.00 | $16.33M |
| Total liabilities | $29.16M | $41.30M | $118.25M | $58.10M | $39.98M | $25.37M |
| Retained earnings | -$719.62M | -$693.23M | -$581.21M | -$348.71M | -$216.12M | -$143.68M |
| Total equity | $44.42M | $35.38M | $96.16M | $249.40M | $337.12M | $35.08M |